10 at 10: These ASX stocks are getting the strongest reception this morning
News
News
Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data.
It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.
The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has commenced trading.
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
Code | Company | Price | % | Volume |
---|---|---|---|---|
CLZ | Classic Min Ltd | 0.0015 | 50 | 36549888 |
ADA | Adacel Technologies | 1.40 | 36 | 544981 |
PCL | Pancontinental Oil | 0.002 | 33 | 250000 |
TSC | Twenty Seven Co. Ltd | 0.004 | 33 | 653757 |
STM | Sunstone Metals Ltd | 0.027 | 23 | 13805061 |
DCX | Discovex Res Ltd | 0.006 | 20 | 341666 |
ARE | Argonaut Resources | 0.0065 | 18 | 4163483 |
AJX | Alexium Int Group | 0.084 | 17 | 3388196 |
DDT | DataDot Technology | 0.007 | 17 | 74990 |
PIL | Peppermint Inv Ltd | 0.014 | 17 | 400072 |
Software stock Adacel Technologies (ASX:ADA) rose thanks to its annual results.
Advanced materials company Alexium Group (ASX:AJX) rose with a sales update.
In resources, base metals explorer Argonaut (ASX:ARE) commenced an exploration campaign at its Nyungu copper-cobalt deposit.
And porphyry hunter Sunstone Metals (ASX:STM) announced hitting a copper porphyry intersection at its project in Ecuador.
Code | Company | Price | % | Volume |
---|---|---|---|---|
DLC | Delecta Limited | 0.005 | -17 | 328571 |
AXP | AXP Energy Ltd | 0.006 | -14 | 6283500 |
KP2 | Kore Potash PLC | 0.014 | -13 | 520933 |
OEX | Oilex Ltd | 0.0035 | -13 | 450000 |
IKW | Ikwezi Mining Ltd | 0.46 | -12 | 22148 |
AVW | Avira Resources Ltd | 0.004 | -11 | 250000 |
EVE | EVE Investments Ltd | 0.004 | -11 | 588800 |
KLR | Kaili Resources Ltd | 0.026 | -10 | 115 |
ANP | Antisense Therapeutics | 0.18 | -10 | 1662051 |
ENV | Enova Mining Limited | 0.027 | -10 | 40150 |
Antisense Therapeutics (ASX:ANP) fell after an update on its endeavours to gain regulatory approval of its ATL1102 drug in the US.